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Retinoic acid (RA), a potent teratogen, produces a characteristic set of embryonic cardiovascular malformations similar to
those observed in neural crest ablated avians. While the effects of RA on neural crest are well described, the molecular
mechanism(s) of RA action on these cells is less clear. The present study examines the relationship between RA and
mitogen-activated protein kinase signaling in neural crest cells and demonstrates that c-Jun N-terminal kinase (JNK)
activation is severely repressed by RA. RA suppressed migration and proliferation of primary cultures of mouse neural crest
cells treated in vitro as well as from animals treated in vivo. On Western blots, JNK activation/phosphorylation in neural
rest cultures was reduced, while neither extracellular signal-regulated kinase (ERK) nor p38 pathways were affected. Both
he dose-dependent stimulation of neural crest outgrowth and JNK phosphorylation by platelet-derived growth factor AA,
hich promotes outgrowth but not proliferation of neural crest cultures, were completely abrogated by RA. To establish the
elevance of the JNK signaling pathway to cardiac neural crest migration, dominant negative adenoviral constructs were
sed to inhibit upstream activation of JNK or c-Jun downstream responses. Both adenoviral constructs markedly reduced
eural crest cell outgrowth, while a dominant negative inhibitor of the p38 pathway had no effect. These data demonstrate
hat the JNK signaling pathway and c-Jun activation are critical for cardiac neural crest outgrowth and are potential targets
or the action of RA. © 2001 Academic Pressw
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1INTRODUCTION
The importance of vitamin A and its active metabolite,
retinoic acid (RA), in embryonic growth and development
has been recognized for nearly 70 years (Hale, 1933). During
this time, an enormous body of work has shown that
retinoids not only are necessary for normal embryonic
growth and development, but also are among the most
potent teratogens known. All vertebrate species tested are
sensitive to RA during embryogenesis. Nearly every major
organ system is susceptible to malformations, each with a
critical developmental period of sensitivity (Shenefelt,
1972; Morriss-Kay, 1992; Collins and Mao, 1999). With the
advent of increased clinical usage of retinoids, a retinoic
acid embryopathy (RAE) has been described in humans with
characteristic phenotypic abnormalities that involve the
craniofacies, cardiac, thymic, and central nervous systems.
(Lammer et al., 1985). Each of these structures is invested
1 To whom correspondence should be addressed. Fax: (513) 636-
5958. E-mail: melissa.colbert@chmcc.org.0012-1606/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.ith neural crest-derived mesenchyme, and thus the neural
rest appears to be particularly susceptible to retinoid-
ediated teratogenesis.
The neural crest is a multipotential, transitory cell popu-
ation that contributes to a variety of disparate tissue types.
hese cells originate in the dorsal neural folds, transform
rom neuroectoderm to ectomesenchyme, and migrate to
arious and often distant sites within the embryo (LeDoua-
in and Kalcheim, 1999). A subset of cranial neural crest,
he cardiac neural crest, has been strongly implicated in
ardiovascular development (Le Lievre and Le Douarin,
975; Kirby et al., 1983; Creazzo et al., 1998). This popula-
ion extends from the midotic placode to the third or fourth
omite and appears to be highly sensitive to retinoids. The
ortic arches and the outflow tract malformations described
n human RAE have long been observed in animals exposed
o high doses of RA (Shenefelt, 1972; Geelen, 1979; Yasui et
l., 1995). These malformations phenocopy defects associ-
ted with ablation of the cardiac neural crest (Kirby et al.,
983; Fukiishi and Morriss-Kay, 1992; Kirby and Waldo,
995). Although the incidence of persistent truncus arterio-351
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352 Li, Molkentin, and Colbertsus, the hallmark of the neural crest ablation phenotype, in
animal models is small, it is nevertheless one of the five
described conotruncal malformations identified in human
RAE (Lammer et al., 1985). The relationship between mal-
formations associated with neural crest ablation and those
resulting from RA teratogenesis is consistent with the
hypothesis that such defects arise because too few cells are
available to populate the developing target organs (Nau et
al., 1994). This explains the outflow tract defects observed
in RAE and major contributing causes could arise from
failure of crest cell migration, proliferation, or survival.
Neural crest subpopulations exhibit distinct dependen-
cies upon specific growth factors, and the ligands for these
growth factor receptors are often located along the path of
migration. For example, migrating cardiac neural crest cells
express platelet-derived growth factor receptor-a
(PDGFRa). The ligand, PDGF AA, is located in the surface
ctoderm, suggesting the importance of ectodermal–
esenchymal signals to the neural crest cells throughout
heir migration into the pharyngeal arches (Orr-Urtreger
nd Lonai, 1992; Ho et al., 1994). It has been hypothesized
that the localization of ligand provides tropic and/or trophic
signals that not only are critical for neural crest migration
but also have the potential to regulate proliferation or act as
survival factors (Wehrle-Haller and Weston, 1997). Deletion
of the PDGFRa in Patch mutant mice results in severe
craniofacial and cardiovascular malformation, including
truncus arteriosus, defects strikingly similar to those de-
scribed in RAE (Morrison-Graham et al., 1992; Schatteman
et al., 1995), and targeted ablation of this receptor affects
neural crest survival and patterning (Soriano, 1997).
Ligand binding to a receptor tyrosine kinase, such as
PDGFRa, stimulates mitogen-activated protein kinase
MAPK) signaling pathways by a variety of mechanisms.
he MAPK cascades most often initiate with Ras or Rac
ctivation (Denhardt, 1996) and proceed through three main
athways: the extracellular signal-regulated kinases (ERKs),
he c-Jun N-terminal kinases (JNKs), or the p38 family of
inases (see Fig. 6B; Davis, 1999; Garrington and Johnson,
999; Schaeffer and Weber, 1999). Mounting evidence sug-
ests that although the pathways are discrete, crosstalk
etween them is not uncommon. These pathways activate
variety of transcriptional regulators, such as c-Jun, Elk,
nd ATF-2, which, in turn, act on target genes to regulate
igration, proliferation, and apoptosis during development
see Widmann et al., 1999 and references therein). More
han one pathway may activate a given transcription factor,
nd these interactions may be cell type-specific. Therefore,
nterference with signaling mechanisms acting through the
RK, the JNK, or p38 branches could have profound conse-
uences on neural crest behavior.
A great deal is now known concerning the regulation of
A-mediated gene expression and the role of RA in embry-
nic pattern formation. Two families of nuclear receptors,
he RARs and RXRs, act as ligand-activated trascription
actors to mediate the action of RA. A large number of
arget genes that are transcriptionally regulated by RA haveCopyright © 2001 by Academic Press. All rightubsequently been identified (Gigue´re, 1994; Chambon,
996). However, the mechanism whereby gene activation
nitiates the specific chain of events that impinges on cell
ehaviors responsible for RA-mediated dysgenesis remains
argely unknown.
We have begun to examine the interaction between RA
nd MAPK signaling in cardiac neural crest. We hypoth-
size that RA-initiated inhibition of MAPK signaling may
ontribute to neural crest teratogenesis. Our data demon-
trate that RA preferentially inhibits JNK phosphorylation,
hat c-Jun activity is critical for neural crest outgrowth, and
herefore that this pathway is a potential target for the
ction of RA.
MATERIALS AND METHODS
Mice
ICR mice were maintained under a 12-h light cycle, and noon of
the day of coital plug visualization was considered 0.5 day postco-
itum (dpc). To verify that cultured cells were predominantly neural
crest, embryos were collected from Pax3-cre 3 Rosa 26 mating
(Soriano, 1999; Li et al., 2000) and cultures prepared as below.
Offspring of these mice show b-galactosidase (bgal) expression in
neuroepithelium and migrating neural crest cells in vivo (Li et al.,
2000). Identical results were obtained with neural crest explants
from SlughlacZ mice. The mouse slug gene, slugh, and slugh-driven
lacZ are expressed only in migratory neural crest cells (Jiang et al.,
1998).
Stock solutions of 30 mg/ml all-trans-RA (Sigma) in DMSO were
prepared under amber light. Embryos were exposed to RA in vivo
by intraperitoneal injection of dams with 70 mg/kg RA 6 or 18 h
prior to sacrifice (Yasui et al., 1995). Control animals received
MSO only. All animals were used in accordance with institu-
ional guidelines for animal care and use.
Neural Crest Cultures
Embryos were isolated at 8.5 dpc. Neural tubes from midotic
placode to the third somite containing the cardiac neural crest
(Huang et al., 1998) were excised in Liebowitz’ L15 medium (Gibco)
with 10% horse serum. The dorsal tube was dissected free of
adherent mesenchyme, split into halves along the midline, and cut
into three to four fragments using tungsten needles. Explants were
transferred to fibronectin-coated dishes containing high glucose
DMEM (Sigma), 10 or 2% horse serum, and antibiotic (Gibco) and
allowed to adhere for 4–6 h prior to the addition of RA. Stock
solutions of all-trans-RA (Sigma) were dissolved in 95% ethanol,
diluted to working concentrations in 95% ethanol, and added to
cultures. All procedures handling RA were carried out under amber
light. Control cultures received ethanol, with final concentration
in all cases of 0.1%.
PDGF AA (Sigma) was resuspended in 4 mM HCl with 0.1%
BSA, and stock solutions were diluted to final concentrations in
medium containing 2% horse serum. Explants were plated directly
into low serum medium with or without PDGF, and RA was added
4–6 h after plating. All cultures were maintained at 37°C, 5% CO2
for 24–48 h, in the dark until processed.s of reproduction in any form reserved.
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353Retinoic Acid Inhibits JNK in Neural CrestQuantitation of Migration and Proliferation
For most analyses, explants were removed after 18–24 h in
culture, and outgrowth was photographed 24 or 48 h after treat-
ment. Bright-field digital images were obtained either directly by
using an Olympus BX60 microscope equipped with a Spot camera
(Diagnostic Instruments) or by scanning 35-mm slides of colonies,
photographed with an Olympus SZH10 stereo microscope under
dark-field illumination, using Sprint Scan 35 Plus (Polaroid). The
relative migration area was determined using NIH Image software
with calculations as described by Huang et al. (1998). Briefly, the
measured area of explant was subtracted from the total outgrowth
area of the resulting colony. To normalize the results for differ-
ences in explant size or shape, the difference in the resulting area
was then divided by the perimeter of the explant (Huang et al.,
1998).
Proliferation was measured following bromodeoxyuridine (BrdU)
incorporation. Cultures were exposed to 10 mM BrdU during the
ast 2 h of incubation. Cells were fixed and stained for BrdU using
treptavidin–biotin (Zymed), and labeled cells and total cells were
ounted using NIH Image software. Proliferation was calculated as
he percentage of BrdU-positive cells in total cell outgrowth.
Protein Gels and Western Blots
Cultures were washed one time with sterile PBS, and the neural
crest cells were scraped into a minimum of extraction buffer. The
buffer contained 20 mM sodium phosphate, 150 mM NaCl, 2 mM
MgCl2, 0.1% Nonidet P-40, 10% glycerol, 10 mM NaF, 0.1 mM
odium orthovanadate, 10 mM sodium pyrophosphate, 1 mM DTT,
0 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin, 10
mg/ml N-tosylphenylalanyl chloromethyl ketone, 10 mg/ml
N-tosyllysyl chloromethyl ketone, to inhibit proteases and phos-
phatases as described (Taigen et al., 2000). Total protein was
determined in extracts (Bio-Rad) and 10–20 mg loaded onto stan-
dard SDS gels. Proteins were transferred to nitrocellulose, and
Western blots were performed (Li et al., 1995) using immunodetec-
tion with ECF substrate (Amersham). Primary antibodies used were
polyclonal against JNK, phospho-JNK, phospho-ERK, phospho-p38
(Cell Signaling), or a monoclonal antibody against total actin (C4;
Lessard, 1988). Blots were quantitated using a Storm 860 Phospho-
rImager (Molecular Dynamics) set for blue fluorescence.
Replication-Deficient Adenovirus Infection
Several different replication-deficient adenoviruses were used in
this study. Adbgal, containing the lacZ gene, was used as a control
or viral infection. Dominant negative modifications of MKK4
AdSEK-1dn; Choukroun et al., 1998, provided by J. Molkentin),
dMKK3 (MKK3 KA, J. Molkentin), and c-Jun (TAM-67; Brown et
l., 1994, provided by R. Serra) were used to inhibit upstream and
ownstream activity in MAPK pathways. Their construction and
haracterization have been described elsewhere (Brown et al., 1994;
aingeaud et al., 1996; Choukroun et al., 1998; De Windt et al.,
2000). Neural crest explants were plated directly into media
containing ;1 3 108 plaque forming units (PFU) of each virus.
Cultures were incubated with virus overnight, the medium was
changed, and incubation was continued for an additional 8 h prior
to processing for migration. Staining of transgenic or virally in-
fected neural crest cultures for bgal expression was as described
previously (Colbert et al., 1993).Copyright © 2001 by Academic Press. All rightStatistics
All data are presented as means 6 SEM. Differences between
treated and control groups were analyzed using Student’s t test for
npaired data. A value of P , 0.05 was considered statistically
ignificant, and all calculations were performed using Instat soft-
are (Graphpad).
RESULTS
Neural Crest Cultures
A system for primary culture of cardiac neural crest cells,
based upon that described by Huang et al. (1998), was
stablished in order to examine the effects of RA directly on
hese cells. Embryos at 8.5 dpc with 8–13 somites were
sed for these studies. At this stage, mouse cardiac crest
ells begin emigration from the occipital neural tube and
rest is particularly sensitive to RA (Fukiishi and Morriss-
ay, 1992; Morriss-Kay et al., 1993). Experiments to verify
hat cells in the outgrowth area were neural crest were
erformed using two different mouse models carrying lacZ-
arked neural crest cells. Cultures from embryos derived
rom Pax3-cre crossed with Rosa 26 mice (Soriano, 1999; Li
t al., 2000), which express lacZ in neural crest following
ecombination, or from explants of SlughlacZ mice (Jiang et
al., 1998) qualitatively demonstrate that almost all of the
migratory cells from the explants are lacZ-positive neural
crest (not shown).
RA Inhibits Cardiac Neural Crest Migration and
Proliferation
Exposure of rodent embryos to RA, in vivo or in whole-
embryo culture, suggests that RA attenuates neural crest
migration (Morriss and Steele, 1974; Pratt et al., 1987;
Mulder et al., 1998). To examine whether in vivo treatment
irectly influenced neural crest migration, dams were
reated with 70 mg/kg of RA 18 h prior to sacrifice. Embryos
rom treated dams exhibited characteristic flattening of the
ranial neural folds, reduction of hindbrain rhombomeres,
nd blebbing of the neuroectoderm (not shown; Yasuda et
al., 1987). Figure 1 shows that colony outgrowth area from
RA-treated explants was reduced compared to control colo-
nies (A, B). Quantitation of relative migration revealed an
approximate 40% decrease in the RA-treated embryos
(Fig. 1C).
Explants from untreated embryos were then cultured in
media containing increasing amounts of RA to determine if
in vitro exposure produced a similar response. Neural crest
outgrowth was sensitive over a range of RA concentrations.
Lower levels of RA (1028 M) had no statistical effect;
owever, a dose-dependent decrease in relative migration
as observed (Fig. 1D). Therefore, RA interferes with sig-
als or processes intrinsic to neural crest cells that affect
olony outgrowth/migration.
Potential differences in outgrowth area might also reflect
educed proliferation of neural crest cells, decreasing thes of reproduction in any form reserved.
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354 Li, Molkentin, and ColbertFIG. 1. Retinoic acid inhibits outgrowth of neural crest cells treated in vivo and in vitro. Dams were treated with 70 mg/kg RA in DMSO
8 h prior to sacrifice. Outgrowth in culture of explants from control (A) or RA-treated (B) embryos is shown and is reduced in explants from
reated embryos. Quantitation shows a 40% decrease in relative migration in the treated animals, P , 0.0001 (C). In vitro, RA exposure
nhibits migration in a dose-dependent fashion (D). Data are the mean of three independent experiments. Bar 5 1 mm.
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355Retinoic Acid Inhibits JNK in Neural Cresttotal number of cells. Proliferation of cardiac neural crest,
cultured from embryos exposed in vivo or explants treated
in vitro, was evaluated by BrdU incorporation in vitro
following 24 h in culture. RA reduced BrdU incorporation
by 45% in cultures treated in vivo and from 19 to 36% in
vivo (Fig. 2). It is unclear what contributes to this difference
in vivo, although it may possibly reflect a developmental
difference between embryos 12 h older. Thus, defective
proliferation could contribute to the decrease in outgrowth.
RA Inhibits PDGF AA-Stimulated Neural Crest
Outgrowth and JNK Activation
The PDGFs are important regulators of both cellular
proliferation and migration (Heldin et al., 1998). The PDGF
AA isoform appears to be of central importance to these
processes, particularly in the early embryo, where PDGFRa
predominates (Ataliotis and Mercola, 1997). While 10%
fetal bovine serum supported neural crest cell migration
and proliferation, we utilized PDGF AA treatment in low
(2%) serum as a more defined stimulus for neural crest
outgrowth. The significant advantage of PDGF AA stimu-
lation is that effects on proliferation were not observed
(Table 1; C. Lo, personal communication). Such a defined
stimulus also permitted a characterization of RA’s effects
on migration versus proliferation. Indeed, PDGF AA pro-
moted a significant outgrowth of neural crest in low serum
medium (Fig. 3A). A dose-dependent increase in cardiac
neural crest migration was observed up to 10 ng/ml; higher
doses of PDGF were slightly inhibitory. When neural crest
cells were cultured in PDGF-containing medium in the
presence of 1026 M RA, all PDGF stimulation of migration
was abolished, irrespective of the amount of the growth
factor added (Fig. 3A). This effect was not due simply to loss
or downregulation of PDGFRa by RA. Immunocytochemi-
FIG. 2. Retinoic acid inhibits proliferation of neural crest cells tre
026 M RA is reduced by 45% at 24 h. Embryos exposed for 18 h ex
h, proliferation is deceased by 19%.Copyright © 2001 by Academic Press. All rightal analyses indicated no decrease in intensity of receptor
taining in RA-treated or control cultures (not shown).
Extracts from PDGF-treated cultures were then analyzed
y Western blot, and activation of the three main MAPK
ignaling pathways was examined approximately 48 h fol-
owing RA treatment. PDGF AA stimulated JNK phosphor-
lation in primary neural crest cultures, while ERK and p38
ctivation remained unchanged (Fig. 3B). Quantitation of
canned images demonstrates that JNK phosphorylation
as increased in proportion to increasing doses of PDGF
Fig. 3C). These results directly parallel the stimulation of
rest cell outgrowth. When RA was added to PDGF-treated
ultures 6 h after plating, the increased phosphorylation of
NK was reduced to levels comparable to untreated controls
Figs. 3B and 3C). Analysis of cultures grown in 10% serum
nd treated with 1026 M RA for an equivalent time shows a
similar specific suppression of JNK activation without
changes in ERK or p38 phosphorylation (not shown). These
results demonstrate that PDGF AA stimulates JNK activa-
tion in cardiac neural crest cells, which is a target for
inhibition by RA.
in vivo and in vitro. Proliferation of cultures treated in vitro with
a 30% reduction in proliferation, whereas in embryos exposed for
TABLE 1
PDGF-Stimulated BrdU Incorporation
PDGF (ng) BrdU incorporation
0 2.8 6 0.9 (13)
5 3.5 6 0.4 (10)
10 2.5 6 0.4 (18)
20 3.3 6 0.7 (10)
Note. Values given are percentages of cells that incorporate BrdU
SEM. Numbers in parentheses are the number of colonies
valuated at each PDGF dose.ated
hibits of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All rightRA Specifically Acts on JNK and Does Not Affect
ERK or p38 Phosphorylation
Since the activation of the ERK and p38 pathways in
response to positive stimulation is generally rapid and
transient, the possibility remained that an early suppres-
sion by RA could have been missed. To determine whether
RA affected early activation of ERK or p38, explants were
plated overnight in media containing low serum. Cultures
were then exposed to 1026 M RA for 6 h. This allows
sufficient time for activation of RA-responsive genes in
vivo (Conlon and Rossant, 1992) and in vitro (R. Converse
and M.C.C., unpublished observations). Neural crest cells
were then harvested 15 min following addition of fresh
media containing 10% serum, and activation of ERK and
p38 in extracts was evaluated on Western blots. Serum
stimulated the phosphorylation of both ERK and p38 to
levels greater than those observed at 48 h; however, activa-
tion at 15 min remained the same, irrespective of RA
treatment (Fig. 4).
Studies were also conducted to examine the timing of
PDGF stimulation and response relative to RA addition. We
found no difference in the response of neural crest cultures
to PDGF, irrespective of whether the cells were pretreated
with RA or RA was added 4–6 h subsequent to PDGF
RA, irrespective of the amount of PDGF AA (A). Western blots
show that PDGF AA increases levels of phosphorylated JNK but
has no effect on either ERK or p38. Levels of total JNK remain
unchanged. C, control, no PDGF AA; R, control plus RA; numbers
above lanes indicate PDGF AA in ng/ml (B). Quantitation of a
representative blot shows the increase in phospho-JNK parallels
the effects on migration (C). Results in A represent means of three
experiments. Trends in B and C were consistently observed
throughout each experiment.
FIG. 4. RA does not alter activation of either ERK or p38. Neural
crest cultures were grown overnight in low-serum-containing me-
dium, treated with 1026 M RA for 6 h, and treated with 10% serum
for 15 min. Western blots of extracts show that ERK and p38
phosporylation are enhanced compared to extracts of cultures
grown for 24 h in normal serum and that activation is unaffected by
RA.FIG. 3. PDGF AA-stimulated neural crest outgrowth and JNK
phosphorylation are abrogated by RA. PDGF stimulates neural
crest outgrowth in a dose-dependent fashion that is abrogated bys of reproduction in any form reserved.
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357Retinoic Acid Inhibits JNK in Neural Cresttreatment (not shown). Taken together, these results dem-
onstrate that JNK signaling was selectively inhibited by RA
in cardiac neural crest cells.
PDGF-Mediated Phosphatidylinositol 3-Kinase
Activity Is Critical for Neural Crest Cell Migration
While our data suggest that JNK signaling may play a role
in neural crest cell migration, the mechanism responsible
for JNK activation in these cells remains to be resolved.
Evidence from other systems has demonstrated that phos-
phatidylinositol 3 (PI3)-kinase signaling in response to
PDGF is important for embryonic mesodermal migration
(Symes and Mercola, 1996) and can activate the JNK path-
way (Lopez-Ilasaca et al., 1997; Assefa et al., 1999). To
determine whether PI3 kinase may potentially mediate this
activity, neural crest cultures were treated with 10 ng of
PDGF AA in the presence of 2 mM wortmannin, which
nhibits PI3 kinase signaling. This treatment blocked
DGF-stimulated neural crest migration (Fig. 5), suggesting
hat PI3 kinase could be a potential upstream signal that
ould then activate JNK.
The JNK Pathway Plays a Critical Role in Neural
Crest Cell Migration
Our results demonstrate that RA interferes with JNK
signaling and suggest that this pathway may be critical for
cardiac neural crest cell outgrowth and migration. To test
this directly, we sought to use replication-deficient adeno-
virus to perturb upstream and downstream components of
this pathway. Since not all cell types are amenable to
adenoviral infection (Goldman and Wilson, 1995; Croyle et
l., 1998; Leon et al., 1998), primary neural crest cultures
FIG. 5. Inhibition of PI3 kinase by wortmannin prevents PDGF-in
% serum (n 5 47), 2% serum plus 10 ng/ml PDGF AA (n 5 40), or
AA increases outgrowth by 60% (P , 0.0001) compared to control,Copyright © 2001 by Academic Press. All rightere first incubated overnight in 108 PFU Adbgal to deter-
ine the efficiency of adenoviral infection. Cultures
tained for lacZ exhibited high levels of infection where
nly the migrating cells were infected, and all of the cells in
he outgrowth area exhibited some level of bgal staining
Fig. 6A). Thus, modified MAPK constructs could be deliv-
red to all cells in the cultures.
Neural crest cultures were subsequently infected with
denovirus carrying modified components of MAPK path-
ays and migration was quantitated 24 h after infection.
ultures were infected with a dominant negative form of
KK4, AdSEK-1dn (Choukroun et al., 1998), an upstream
inase that activates JNK (Fig. 6B). This construct inhibited
eural crest migration by 38% (Fig. 6C, P 5 0.0002) and
einforces the importance of JNK activation in this process.
owever, in vitro data suggest that MKK4 can also activate
38 substrates (Davis, 1999). Therefore, to test whether the
nhibition observed was specific for JNK, cultures were
nfected with a dominant negative MKK3 virus (MKK3 KA;
aingeaud et al., 1996), which acts specifically on p38. The
KK3 construct did not inhibit neural crest outgrowth (Fig.
C, P 5 0.5042), thus confirming the specificity of MKK4
or JNK in these cells and the subsequent effects on out-
rowth. The primary target for JNK phosphorylation is
-Jun, a major component of the AP-1 complex. To deter-
ine whether inhibition of c-Jun activation also reduced
ardiac neural crest cell migration, a dominant negative
-Jun virus (TAM-67; Brown et al., 1994) was used to infect
eural crest cultures. TAM-67 inhibited neural crest out-
rowth 49% compared to the Adbgal control (P , 0.0001).
Taken together, our data show that RA inhibits JNK phos-
phorylation and that suppression of this pathway upstream
or downstream of JNK has significant negative effects on
neural crest behavior.
d neural crest cell outgrowth. Neural crest cultures were grown in
erum, 10 ng/ml PDGF AA, and 2 mM wortmannin (n 5 46). PDGF
wortmannin treatment reduced outgrowth to near control values.duce
2% s
ands of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All rightDISCUSSION
Retinoic acid affects a variety of cell types and processes
during embryonic development. The pleiotropic effects of
RA suggest that targets may include multiple gene sets and
different developmental pathways. Previous studies clearly
show that RA treatment leads to misexpression of Hox gene
family members that results in mispatterning of the hind-
brain and pharyngeal arches (Conlon and Rossant, 1992;
Marshall et al., 1996; Mulder et al., 1998). However, this
fails to address how RA influences fundamental cellular
functions. Previous studies have shown that retinoids pro-
foundly impair neural crest migration (Thorogood et al.,
1982; Wiley et al., 1983; Pratt et al., 1987; Lee et al., 1995;
Mulder et al., 1998) and proliferation (Henion and Weston,
1994; Ito and Morita, 1995; Salvarezza and Rovasio, 1997) in
embryos and cells treated in vivo or in vitro. Consistent
with these findings, our data show quantitative inhibition
of neural crest cell migration and proliferation. Further-
more, these biological effects are accompanied by decreased
MAPK signaling. Thus, we have identified one possible
mechanism for the teratogenic action of RA on cardiac
neural crest cells. The data presented clearly show that RA
interferes with intracellular signal transduction by inhibit-
ing JNK phosphorylation and that this signaling pathway is
critical for normal cardiac neural crest outgrowth in vitro.
RA and Growth Factor Antagonism
Antagonism between specific growth factors and RA is
well supported experimentally and directly affects prolifera-
tion and migration. For example, RA suppresses the mito-
genic response of smooth muscle cells to PDGF BB and to
endothelin (ET)-1 (Miano et al., 1996; Chen and Gardner,
1998). The action of proangiogenic agents, such as TNF a
and VEGF, that promote endothelial cell proliferation and
chemotaxis is blocked by RA as well as other nuclear
hormone family members (Gonzalez et al., 1999). Our data
how a specific antagonistic effect between RA and PDGF
A-stimulated outgrowth of neural crest cells in culture.
were infected. (B) Generalized scheme of receptor tyrosine kinase
signaling. Ligand binding to receptor on the surface membrane
activates ras and starts the intracellular cascade. A MAP kinase
kinase kinase (MAPKKK) is the first target, which then activates a
family of MAP kinase kinase (MAPKK) molecules to which
MEK1,2, MKK4, and MKK3 belong. Each MAPKK is specific.
MEK1,2 acts on ERKs, MKK4 on JNKs, and MKK3 on p38s,
although some evidence suggests that, in vitro, MKK4 may also
activate p38 (see Davis, 1999 for further details). A final nuclear
target for JNK activation is c-Jun. Adenovirus that carried domi-
nant negative (dn) constructs of MKK4, MKK3, and c-Jun was used
to infect neural crest cultures and their effect on cell outgrowth
was determined (C). The lacZ-containing adenovirus was used as
control (Adbgal). The Ad MKK4 dn and Ad c-Jun dn virus severely
nhibited relative migration, while the Ad MKK3 dn had no effect.FIG. 6. Inhibition of components of the JNK signal cascade by
dominant negative adenovirus inhibits neural crest outgrowth. (A)
Adenovirus efficiently infects primary cultures of neural crest
cells. Explants were plated into 1.2 3 108 PFU/ml, cultured for
4 h, and stained for lacZ expression. All cultures showed high
evels of lacZ expression, and all cells migrating from each explants of reproduction in any form reserved.
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359Retinoic Acid Inhibits JNK in Neural CrestPDGF AA, the primary isoform in the early embryo, is an
important signal for neural crest cells. Crest cells carry the
PDGR receptor (PDGFR)a, while the overlying ectodermal
ells express PDGF AA (Orr-Urtreger and Lonai, 1992; Ho et
l., 1994). Mutational analysis in knock-out animals has
hown that loss of the PDGFRa profoundly affects neural
rest survival and pattern formation (Soriano, 1997). The
atch mouse, a spontaneously occurring mutant with a
eleted PDGFRa, exhibits a variety of cardiovascular mal-
ormations, including persistent truncus arteriousus
Morrison-Graham et al., 1992; Schatteman et al., 1992;
chatteman et al., 1995). Since RA interferes with PDGF
ignaling in vitro, its function may be targeted by terato-
enic doses of RA in vivo as well.
The PDGF receptor initiates a variety of cellular re-
ponses. The interaction of SH2 domain-containing mol-
cules with phosphorylated docking sites on the receptor
ctivates different signaling pathways (for review see Hel-
in et al., 1998). Activation of phosphatidylinositol 39-
inase and the Rho family of small GTP-binding proteins
lays a role in chemotactic responses to PDGFRa (Rosen-
ranz et al., 1999; Rosenkranz and Kazlauskas, 1999).
urthermore, PDGFRb activation of PI3-kinase also acti-
vates JNK signaling (Lopez-Ilasaca et al., 1997). While this
as not been verified for PDGFRa, our observation that
wortmannin inhibits PDGF AA-stimulated outgrowth sug-
gests a similar signaling mechanism may be operational.
The fact that RA abrogates PDGF AA-stimulated migration
and prevents phosphorylation of JNK insinuates a link
between JNK-signaling and PI3 kinase activation by
PDGFRa, although this remains unproven. Additional ex-
eriments are in progress to test this relation.
We have observed that RA inhibits PDGF AA-mediated
utgrowth and activation of JNK; however, PDGF, most
ikely, is not the only growth factor target. Similar inhibi-
ion of JNK phosphorylation also occurs under standard,
igh serum culture conditions that contain a host of growth
actors. Thus, RA has the potential to influence other
ediators that act through JNK.
Migration vs Proliferation
Our data show that, in high-serum-containing medium,
RA inhibits both neural crest cell migration and prolifera-
tion. Serum is a complex and undefined mixture of various
factors, including PDGF and other signals. JNK activation
was targeted under both high and low serum conditions.
Since neural crest cultures proliferate very poorly in re-
duced serum and PDGF AA cannot compensate for loss of
those signals, it is likely that serum stimulation activates
other pathways that are involved in proliferation. It does
appear that at least a subset of serum effects, mediated by
PDGF, utilize JNK signaling for outgrowth. Preliminary
studies in vitro suggest that neural crest proliferation is
nly minimally affected by the TAM 67 virus and loss of
-Jun activity (R. Converse and M.C.C., unpublished obser-
ations). The specific effects of RA on proliferation, the
elative contribution of these alterations to neural crest cellCopyright © 2001 by Academic Press. All rightigration, and the signals involved remain to be resolved
nd are the current focus of continuing experimentation.
RA, JNK, and AP-1
It has been reported that ligand activation of the nuclear
hormone receptor superfamily, including RA/RARs, an-
tagonize JNK activation (Caelles et al., 1997). Subsequent
tudies show that ERK and JNK signaling are also inhibited
y RA in normal human bronchial epithelial cells induced
y EGF (Lee et al., 1998), in endothelial cells treated with
umor necrosis factor-a or VEGF (Gonzalez et al., 1999), and
non-small-cell lung cancer cells stimulated by serum (Lee
et al., 1999). Our results show that, in primary cultures of
neural crest, phosphorylation of ERK1/2 is not inhibited.
Serum stimulated ERK activation to the same extent in the
presence or absence of RA. Therefore, the JNK pathway is
preferentially targeted in the cardiac neural crest cultures.
c-Jun, the primary transcriptional regulator activated by
JNK, is a component of the AP-1 transcriptional complex.
The antagonism between RA and the AP-1 has long been
recognized and is well documented. Numerous mecha-
nisms have been invoked that include competition for
DNA binding sites (Schule et al., 1990), direct disruption of
jun/fos dimerization (Zhou et al., 1999), and the inhibition
of c-Jun phosphorylation. AP-1 and c-Jun have been impli-
cated in a variety of cell functions and are strongly associ-
ated with signals that regulate cellular proliferation. The
recent ablation of c-Jun produced some rather surprising
results with a very specific phenotype rather than a gener-
alized affect on proliferation. Null embryos die around 13
dpc. Initially, the cause of death was attributed to a defect
in liver development (Hilberg et al., 1993). Interestingly,
19/19 null embryos also had persistent truncus arteriosus
and abnormal remodeling of the aortic arches (Eferl et al.,
1999). The cardiac defects observed in c-Jun null mice
support our data that adenoviral-mediated inhibition of
JNK signaling through c-Jun in neural crest cultures pro-
foundly impairs cell outgrowth. Furthermore, it strength-
ens the association between the teratogenic actions of RA
and JNK signaling.
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